(Q34071283)

30 July 2017

1 reference

title

Update on D2E7: a fully human anti-tumour necrosis factor alpha monoclonal antibody (English)

1 reference

30 July 2017

0 references

1 reference

Kempeni J

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Annals of the Rheumatic Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

59 Suppl 1

1 reference

30 July 2017

page(s)

i44-5

1 reference

The links between joint damage and disability in rheumatoid arthritis

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

Clinical management of rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766613

Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity

5 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11053087

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.59.SUPPL_1.I44

1 reference

30 July 2017

1 reference

30 July 2017

1 reference